Vaccines and Immunomodulatory Therapies for Tularemia

The present invention relates to attenuated strains of Francisella tularensis from which genes in the guanine nucleotide biosynthetic pathway have been deleted and to methods for making the mutants. The invention further relates to the use of the attenuated strains to make vaccines.

Patents:
US 20,110,020,399

Inventor(s): SANTIAGO ARACELI [US]; LEVINE MYRON M [US]; BARRY EILEEN M [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent